Hui Yin

3.9k total citations · 2 hit papers
92 papers, 2.8k citations indexed

About

Hui Yin is a scholar working on Endocrinology, Diabetes and Metabolism, Oncology and Molecular Biology. According to data from OpenAlex, Hui Yin has authored 92 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Endocrinology, Diabetes and Metabolism, 24 papers in Oncology and 23 papers in Molecular Biology. Recurrent topics in Hui Yin's work include Diabetes Treatment and Management (29 papers), Metabolism, Diabetes, and Cancer (19 papers) and Prostate Cancer Treatment and Research (12 papers). Hui Yin is often cited by papers focused on Diabetes Treatment and Management (29 papers), Metabolism, Diabetes, and Cancer (19 papers) and Prostate Cancer Treatment and Research (12 papers). Hui Yin collaborates with scholars based in Canada, Germany and United States. Hui Yin's co-authors include Laurent Azoulay, Samy Suissa, Oriana Hoi Yun Yu, Kristian B. Filion, Anthony S.‐Y. Leong, Francesco Lapi, Christel Renoux, Antonios Douros, Sharon J. Nessim and Michaël Pollak and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and Blood.

In The Last Decade

Hui Yin

89 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effect of combination treatment with glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors on incidence of cardiovascular and serious renal events: population based cohort study

2024 55 citations Hui Yin, Oriana Hoi Yun Yu et al. BMJ profile →
Glucagon-like peptide-1 receptor agonists and risk of suicidality among patients with type 2 diabetes: active comparator, new user cohort study

2025 16 citations Hui Yin, Oriana Hoi Yun Yu et al. BMJ profile →

Peers

Countries citing papers authored by Hui Yin

Since Specialization

Citations

This map shows the geographic impact of Hui Yin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hui Yin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hui Yin more than expected).

Fields of papers citing papers by Hui Yin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hui Yin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hui Yin. The network helps show where Hui Yin may publish in the future.

Co-authorship network of co-authors of Hui Yin

This figure shows the co-authorship network connecting the top 25 collaborators of Hui Yin. A scholar is included among the top collaborators of Hui Yin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hui Yin. Hui Yin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Impact of deep inspiration breath-hold (DIBH) on dose distribution and radiobiological effects in left-sided breast irradiation: A comparative study of IMRT and VMAT techniques under DIBH and free breathing conditions 2025 ·Journal of Radiation Research and Applied Sciences ·Weiwei Wu, (unknown), Hui Yin, Zhiwei Liu, Fangfang Xie	0
2	An assessment of ChatGPT in error detection for thyroid ultrasound reports: A comparative study with ultrasound physicians 2025 ·Digital Health ·(unknown), (unknown), (unknown), (unknown), Hui Yin, Yanru Li, (unknown), (unknown), (unknown), Shaohui Li	0
3	Incretin-Based Drugs and the Incidence of Endometrial Cancer Among People with Type 2 Diabetes: Active Comparator New-User Design 2025 ·Drug Safety ·(unknown), Hui Yin, Oriana Hoi Yun Yu, Michaël Pollak, Laurent Azoulay	1
4	Glucagon-like peptide-1 receptor agonists and risk of suicidality among patients with type 2 diabetes: active comparator, new user cohort study breakdown → 2025 ·BMJ ·(unknown), Hui Yin, Oriana Hoi Yun Yu, Soham Rej, Samy Suissa, Laurent Azoulay	16
5	Dipeptidyl Peptidase-4 Inhibitors and the Risk of Gallbladder and Bile Duct Disease Among Patients with Type 2 Diabetes: A Population-Based Cohort Study 2024 ·Drug Safety ·(unknown), Hui Yin, Oriana Hoi Yun Yu, Laurent Azoulay	4
6	Sodium‐glucose cotransporter‐2 inhibitors and the risk of lung cancer among patients with type 2 diabetes 2024 ·British Journal of Clinical Pharmacology ·(unknown), Hui Yin, Oriana Hoi Yun Yu, Laurent Azoulay	2
7	Assessment of ovarian reserve function in patients with adenomyosis and ovarian endometriosis by three-dimensional transvaginal ultrasound and Anti-Müllerian hormone 2024 ·Scientific Reports ·Hui Yin, Jiemin Chen, Qiuyue Chen, Guorong Lyu	0
8	Contemporary trends in the utilization of second‐line pharmacological therapies for type 2 diabetes in the United States and the United Kingdom 2023 ·Diabetes Obesity and Metabolism ·Devin Abrahami, Elvira D’Andrea, Hui Yin, Seoyoung C. Kim, Julie M. Paik, Deborah J. Wexler, Laurent Azoulay, Elisabetta Patorno	18
9	Incretin based drugs and risk of cholangiocarcinoma among patients with type 2 diabetes: population based cohort study 2018 ·BMJ ·Devin Abrahami, Antonios Douros, Hui Yin, (unknown), Jean‐Luc Faillie, François Montastruc, Robert W. Platt, Nathaniel Bouganim, Laurent Azoulay	47
10	Angiotensin converting enzyme inhibitors and risk of lung cancer: population based cohort study 2018 ·BMJ ·Blánaid Hicks, Kristian B. Filion, Hui Yin, Lama Sakr, Jacob A. Udell, Laurent Azoulay	138
11	Metformin and the Incidence of Lymphoid Malignancies in Patients with Type 2 Diabetes 2017 ·Blood ·Adi J. Klil‐Drori, Hui Yin, Michaël Pollak, Laurent Azoulay	1
12	Persistence with Generic Imatinib for Chronic Myeloid Leukemia: A Matched Cohort Study 2017 ·Blood ·Adi J. Klil‐Drori, Hui Yin, Laurent Azoulay, (unknown), (unknown), Michel‐Olivier Gratton, Lambert Busque, Sarit Assouline	1
13	Glucagon-like peptide-1 analogues and risk of breast cancer in women with type 2 diabetes: population based cohort study using the UK Clinical Practice Research Datalink 2016 ·BMJ ·Blánaid Hicks, Hui Yin, Oriana Hoi Yun Yu, Michaël Pollak, Robert W. Platt, Laurent Azoulay	39
14	Phosphodiesterase Type 5 Inhibitors and the Risk of Melanoma Skin Cancer 2016 ·European Urology ·Lian Yi, Hui Yin, Michaël Pollak, Serge Carrier, Robert W. Platt, Samy Suissa, Laurent Azoulay	27
15	Use of Calcium Channel Blockers and Risk of Breast Cancer 2016 ·Epidemiology ·Laurent Azoulay, (unknown), Hui Yin, Nathaniel Bouganim	19
16	Type 2 diabetes and the risk of mortality among patients with prostate cancer 2014 ·Cancer Causes & Control ·(unknown), Hui Yin, Samy Suissa, Michaël Pollak, Laurent Azoulay	54
17	Metformin and low levels of thyroid-stimulating hormone in patients with type 2 diabetes mellitus 2014 ·Canadian Medical Association Journal ·Jean‐Pascal Fournier, Hui Yin, Oriana Hoi Yun Yu, Laurent Azoulay	29
18	Investigating the discernible and distinct effects of platinum-based chemotherapy regimens for metastatic triple-negative breast cancer on time to progression 2014 ·Oncology Letters ·Daniel Khalaf, John Hilton, Mark Clemons, Laurent Azoulay, Hui Yin, Lisa Vandermeer, Susan Dent, Sean Hopkins, Nathaniel Bouganim	8
19	Androgen deprivation therapy and the risk of colorectal cancer in patients with prostate cancer 2013 ·Cancer Causes & Control ·Jonathan Assayag, Hui Yin, Serge Benayoun, Michaël Pollak, Samy Suissa, Laurent Azoulay	5
20	Concurrent use of diuretics, angiotensin converting enzyme inhibitors, and angiotensin receptor blockers with non-steroidal anti-inflammatory drugs and risk of acute kidney injury: nested case-control study 2013 ·BMJ ·Francesco Lapi, Laurent Azoulay, Hui Yin, Sharon J. Nessim, Samy Suissa	274

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact